The past few years have been boom times for synthetic biology. Today, in a big test for public markets’ appetite for the emerging field, Zymergen raised $500 million in an initial public offering s…
Get Started for FREE
Sign up with Facebook Sign up with X
I don't have a Facebook or a X account
Your new post is loading...
Your new post is loading...
|